drugset / Trial / NCT02044549
Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section
RandomizedParallel-groupDouble-blindPrevention
Summary
to compare effectiveness and tolerability of carbetocin versus syntometrine in prevention of Postpartum hemorrhage after cesarean section
Timeline
- Start
- 2014-06
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | Oxytocin | Peptide | 5 iu | Intravenous |
| Comparator | ergometrine | Unknown | 0.2 mg | Intravenous |
Indications
No indication recorded.